SCHEMBL2340188

SCHEMBL2340188

COc1ccc2c(c1)C(c1ccccc1)=NCC2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.62
LMNA P02545 1/20 0.62
MAPK10 P53779 10/20 0.61
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
CA14 Q9ULX7 1/20 0.54
MAOA P21397 1/20 0.51
NPY5R Q15761 2/20 0.51
MAPK14 Q16539 2/20 0.48
MAPK9 P45984 1/20 0.48
PDE4A P27815 1/20 0.47
PDE1A P54750 1/20 0.47
PDE1B Q01064 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
PDE3B Q13370 1/20 0.47
PDE1C Q14123 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6715284 0.88 CA1 (0.68) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL12567716 0.82 ALDH1A1 (0.65) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL29498350 0.82 ALDH1A1 (0.65) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL29498357 0.82 ALDH1A1 (0.65) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL28338943 0.81 HTR7 (0.55) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL7702378 0.81 NPY5R (0.54) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL30979840 0.81 MAPK10 (0.80) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL5355121 0.81 MAPK10 (0.80) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL28531265 0.80 MAPK10 (0.55) ALDH1A1LMNAMAPK10CA1CA2
SCHEMBL10425997 0.79 ALDH1A1 (0.51) ALDH1A1LMNAMAPK10CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367700-B2 Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-02-05 US disclosed
EP-2358681-A1 SUBSTITUTED 4-(1,2,3,4-TETRAHYDROISOCHINOLIN-2-YL)-4-OXO-BUTYRIC ACID AMIDE AS KCNQ2/2 MODULATORS Grünenthal GmbH (DE) 2011-08-24 EP disclosed
WO-2010075973-A1 SUBSTITUTED 4-(1,2,3,4-TETRAHYDROISOCHINOLIN-2-YL)-4-OXO-BUTYRIC ACID AMIDE AS KCNQ2/2 MODULATORS Grünenthal GmbH (DE) 2010-07-08 WO disclosed
US-20100152234-A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators GRUNENTHAL GMBH (DE) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152234-A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators KCNAB1, KCNQ2, KCNQ1 ALDH1A1 2801/4885LMNA 2050/4885MAPK10 2674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.